Loading clinical trials...
Loading clinical trials...
This study will determine the frequency of adverse events (side effects) in patients with relapsed or refractory small cell lung cancer (SCLC) when given nivolumab and irinotecan together followed by ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Augusta University
NCT06772623 · Non Small Cell Lung Carcinoma
NCT06992609 · Small Cell Lung Carcinoma
NCT07369596 · Non Small Cell Lung Carcinoma NSCLC
NCT06712355 · Extensive-stage Small-cell Lung Cancer
NCT07005128 · Small-cell Lung Cancer, Extensive Stage Small-cell Lung Cancer
Georgia Cancer Center at AU Medical Center
Augusta, Georgia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions